Who owns COGENT BIOSCIENCES INC?
- Ticker: COGT
- CUSIP Number: 19240q201
Tip: Access positions for across all investors
Analyze quarterly positions in Cogent Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cogent Biosciences stock
Who bought or sold COGENT BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| Perceptive Advisors | 3.2M | $28M | 0% | Mar 2021 | ||
| Henderson Group | 2.3M | $20M | 32% | Mar 2021 | ||
| Vanguard Group | 2.1M | $19M | 149% | Mar 2021 | ||
| Logos Global Management | 1.9M | $22M | 100% | Dec 2020 | ||
| Ally Bridge Group | 1.6M | $14M | 0% | Mar 2021 | ||
| Ghost Tree Capital | 1.6M | $14M | 45% | Mar 2021 | ||
| Fairmount Funds Management | 1.6M | $14M | 0% | Mar 2021 | ||
| BVF | 1.5M | $17M | 100% | Dec 2020 | ||
| Citadel Advisors | 1.3M | $37k | 52% | Mar 2021 | ||
| Commodore Capital | 1.3M | $11M | 67% | Mar 2021 | ||
| VR Adviser | 1.1M | $9.6M | 0% | Mar 2021 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Cogent Biosciences? |
||||||
| RA Capital Management | 1.0M | $12M | 100% | Dec 2020 | ||
| Deerfield Management Company | 1.0M | $11M | 100% | Dec 2020 | ||
| Hillhouse Capital Advisors | 1.0M | $11M | 100% | Dec 2020 | ||
| Polar Capital Holdings | 1.0M | $8.8M | -16% | Mar 2021 | ||
| Atlas Venture Associates IX | 917k | $8.0M | 0% | Mar 2021 | ||
| Sphera Funds Management | 763k | $6.7M | 4% | Mar 2021 | ||
| Platinum Investment Mangement | 732k | $6.4M | 54% | Mar 2021 | ||
| Invesco | 703k | $6.2M | 0% | Mar 2021 | ||
| OrbiMed Advisors | 655k | $7.4M | 100% | Dec 2020 | ||
| Point72 Asset Management | 612k | $5.4M | 51% | Mar 2021 | ||
| Farallon Capital Management | 600k | $5.3M | 0% | Mar 2021 | ||
| Axa | 568k | $5.0M | 45% | Mar 2021 | ||
| BlackRock | 568k | $5.0M | -4% | Mar 2021 | ||
| Driehaus Capital Management | 566k | $5.0M | -12% | Mar 2021 | ||
| Hambrecht & Quist Capital Management | 538k | $4.7M | 0% | Mar 2021 | ||
| New Leaf Venture Partners | 502k | $4.4M | 2% | Mar 2021 | ||
| Candriam Luxembourg S.C.A. | 475k | $5.1M | 0% | Mar 2021 | ||
| Avidity Partners Management | 418k | $3.7M | -20% | Mar 2021 | ||
| Citigroup | 293k | $2.6M | 628% | Mar 2021 | ||
| Susquehanna International | 284k | $2.5M | 100% | Mar 2021 | ||
| Jpmorgan Chase & Co | 248k | $2.2M | 269% | Mar 2021 | ||
| Geode Capital Management | 247k | $2.2M | 16% | Mar 2021 | ||
| DAFNA Capital Management | 224k | $2.0M | 100% | Mar 2021 | ||
| ExodusPoint Capital Management | 218k | $1.9M | 61% | Mar 2021 | ||
| Moore Capital Management | 124k | $1.1M | 9% | Mar 2021 | ||
| Schonfeld Strategic Advisors | 123k | $1.4M | 100% | Dec 2020 | ||
| Northern Trust | 60k | $528k | 13% | Mar 2021 | ||
| Hrt Financial | 60k | $526k | 100% | Mar 2021 | ||
| Qube Research & Technologies | 49k | $431k | 100% | Mar 2021 | ||
| Bridgeway Capital Management | 48k | $422k | 3% | Mar 2021 | ||
| Quantitative Systematic Strategies | 48k | $419k | 29% | Mar 2021 | ||
| Millennium Management | 46k | $517k | 100% | Dec 2020 | ||
| Ikarian Capital | 42k | $367k | 0% | Mar 2021 | ||
| Goldman Sachs Group | 39k | $341k | 277% | Mar 2021 | ||
| LMR Partners | 35k | $307k | 100% | Mar 2021 | ||
| Virtus ETF Advisers | 28k | $247k | 100% | Mar 2021 | ||
| Sectoral Asset Management | 27k | $237k | 100% | Mar 2021 | ||
| Bank of America Corporation | 25k | $220k | 91% | Mar 2021 | ||
| State Street Corporation | 20k | $177k | 0% | Mar 2021 | ||
| Wexford Capital | 20k | $176k | 0% | Mar 2021 | ||
| Engineers Gate Manager | 19k | $163k | 100% | Mar 2021 | ||
| Private Wealth Advisors | 16k | $195k | 100% | Dec 2020 | ||
| Cannon Global Investment Management | 14k | $121k | 100% | Mar 2021 | ||
| Diametric Capital | 14k | $121k | 100% | Mar 2021 | ||
| Squarepoint Ops | 12k | $138k | 100% | Dec 2020 | ||
| Boothbay Fund Management | 11k | $98k | 100% | Mar 2021 | ||
| LPL Financial | 11k | $97k | 100% | Mar 2021 | ||
| Veritable | 10k | $88k | 100% | Mar 2021 | ||
| Maven Securities | 3.5k | $31k | 100% | Mar 2021 | ||
| Global Retirement Partners | 1.8k | $16k | 7% | Mar 2021 | ||
| Acadian Asset Management | 610.00 | $5.0k | 100% | Mar 2021 | ||
| Bessemer | 282.00 | $2.0k | 100% | Mar 2021 | ||
| Wells Fargo & Company | 165.00 | $999.999000 | -1% | Mar 2021 | ||
| Bank Julius Baer & Co. Ltd, Zurich | 66.00 | $999.999000 | -26% | Mar 2021 | ||
| PanAgora Asset Management | 5.00 | $0 | 100% | Mar 2021 | ||
| FMR | 3.00 | $0 | -100% | Mar 2021 | ||
Who sold out of Cogent Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Morgan Stanley | Dec 2020 | 930k | $10M |
| Consonance Capital | Dec 2020 | 610k | $6.8M |
| Samsara BioCapital | Dec 2020 | 589k | $6.6M |
| Altium Capital Management | Dec 2020 | 433k | $4.9M |
| Silverarc Capital Management | Dec 2020 | 235k | $2.6M |
| Renaissance Technologies | Dec 2020 | 32k | $364k |
| Two Sigma Advisers | Dec 2020 | 30k | $341k |
| Mirabella Financial Services | Dec 2020 | 29k | $325k |
| Susquehanna Fundamental Investments | Dec 2020 | 26k | $287k |
| Pinz Capital Management | Dec 2020 | 20k | $225k |
| Jump Financial | Dec 2020 | 18k | $149k |
| Gainplan | Dec 2020 | 15k | $168k |
| Capstone Investment Advisors | Dec 2020 | 15k | $164k |
| Trexquant Investment | Dec 2020 | 13k | $148k |
| Occudo Quantitative Strategies | Dec 2020 | 11k | $124k |
| Royal Bank of Canada | Dec 2020 | 123.00 | $1.0k |